Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.
C Lorente-SorollaJ BernaolaD Sánchez-MelladoMarta Gil-MartínezSara Naharro-GonzálezDiana BetancorM Fernández-NietoE J Pinillos-RoblesJ M Santillán CoelloJose Miguel Villacampa AubáMaria Jesus Rodríguez-NietoJoaquin SastreMarcela Valverde-MongeJosé Manuel Rodrigo-MuñozVictoria Del PozoPublished in: Allergy (2023)